HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lidl Recalls Hemp Products Across EU Due To Elevated THC Levels

Executive Summary

Retailer Lidl is recalling hemp products sold across the EU which contain elevated levels of THC, warning consumers that consumption may cause undesirable health effects, such as mood swings and fatigue.”

You may also be interested in...



Belgium Leading The Charge Against Unauthorized CBD Supplements Sold In EU

With no CBD product yet approved under Europe’s novel foods regulation, Belgium is cracking down on unauthorized supplements and alerting its neighbors, an analysis by HBW Insight reveals. 

German CBD Regulation ‘Moving Slowly In The Right Direction’

A recent court case and an upcoming federal election promise movement in Germany's cannbidiol market, stated Joscha Krauss, CEO of local manufacturer MH Medical Hemp GmbH, at the 18th European Industrial Hemp Association (EIHA) Annual Conference.

Ireland Reviewing Codeine's OTC Status

Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151714

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel